Search hospitals > Virginia > Charlottesville

University of Virginia Health System

Claim this profile
Charlottesville, Virginia 22901
Global Leader in Fibrosis
Global Leader in Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Coronary Artery Disease
Conducts research for Lung Cancer
398 reported clinical trials
51 medical researchers
Photo of University of Virginia Health System in CharlottesvillePhoto of University of Virginia Health System in CharlottesvillePhoto of University of Virginia Health System in Charlottesville

Summary

University of Virginia Health System is a medical facility located in Charlottesville, Virginia. This center is recognized for care of Fibrosis, Cancer, Non-Small Cell Lung Cancer, Coronary Artery Disease, Lung Cancer and other specialties. University of Virginia Health System is involved with conducting 398 clinical trials across 435 conditions. There are 51 research doctors associated with this hospital, such as Linda Duska, MD, Scott Lim, MD, Richard D. Hall, and Michael Keng.

Area of expertise

1Fibrosis
Global Leader
University of Virginia Health System has run 19 trials for Fibrosis. Some of their research focus areas include:
CFTR
F508del
minimal function mutation
2Cancer
Global Leader
University of Virginia Health System has run 18 trials for Cancer. Some of their research focus areas include:
Stage III
Stage IV
EGFR positive

Top PIs

Clinical Trials running at University of Virginia Health System

Prostate Cancer
Tumors
Ovarian Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Coronavirus
Solid Tumors
Lung Cancer
Multiple Sclerosis
Cancer
Image of trial facility.

Opevesostat

for Prostate Cancer

This is a phase 3, randomized, open-label study of opevesostat compared to alternative abiraterone acetate or enzalutamide in participants with metastatic castration-resistant prostate cancer (mCRPC) with respect to overall survival (OS) and to radiographic progression-free survival (rPFS) per Prostate Cancer Working Group (PCWG) Modified Response Evaluation Criteria In Solid Tumors (RECIST 1.1) as assessed by blinded independent central review (BICR) in participants with mCRPC previously treated with next-generation hormonal agent (NHA) and taxane-based chemotherapy. It is hypothesized that opevesostat is superior with respect to OS and rPFS per PCWG Modified RECIST 1.1 as assessed by BICR in androgen receptor ligand binding domain (AR LBD) mutation-negative and -positive participants.
Recruiting2 awards Phase 310 criteria
Image of trial facility.

Opevesostat + Hormone Therapy

for Prostate Cancer

This trial is testing a new drug called opevesostat for advanced prostate cancer patients who don't respond to usual care. The drug aims to stop the cancer from growing and spreading, potentially helping patients live longer.
Recruiting2 awards Phase 310 criteria
Image of trial facility.

CPI-0209

for Cancer and Lymphoma

First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas. CPI-0209 is a small molecule inhibitor of EZH2.
Recruiting1 award Phase 1 & 28 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Virginia Health System?
University of Virginia Health System is a medical facility located in Charlottesville, Virginia. This center is recognized for care of Fibrosis, Cancer, Non-Small Cell Lung Cancer, Coronary Artery Disease, Lung Cancer and other specialties. University of Virginia Health System is involved with conducting 398 clinical trials across 435 conditions. There are 51 research doctors associated with this hospital, such as Linda Duska, MD, Scott Lim, MD, Richard D. Hall, and Michael Keng.
Where is University of Virginia Health System located?
The University of Virginia Health System hospital is located at 1215 Lee Street, Charlottesville, VA 22903, on the main campus of the University of Virginia, near the intersection of Lee Street and Jefferson Park Avenue.
Who should I call to ask about financial aid or insurance network?
**University of Virginia Health System Financial Assistance:** - For financial aid, call 866.320.9659 or apply online with the English or Spanish (PDF) forms. - Eligibility is based on a sliding scale of assets, income, and household size, with qualifications including household income within specified ranges and assets under $50,000. **Insurance Inquiries:** - Contact UVA Imaging Billing and Insurance at 866-965-1910 for insurance-related questions. - They accept most major commercial insurance and assist patients with other coverages. Verify coverage with your insurance company before scheduling services. **Graduate Student Health Insurance Subsidy:** - The University mandates health insurance for all students. - Eligible graduate students can receive a Health Insurance Subsidy for the Aetna Student Health plan. - Subsidies may also be available from individual schools or departments for students not meeting initial qualifications.
What insurance does University of Virginia Health System accept?
The University of Virginia Health System accepts a range of insurance plans, including but not limited to the University of Virginia Health Plan, Anthem HealthKeepers Plus (Medicaid), Anthem CCC Plus, Blue Cross and Blue Shield Service Benefit Plan (FEP), Aetna, Cigna, Humana, and Innovation Health. It is important to contact the hospital directly to confirm if your specific insurance plan is accepted, as coverage may vary for different services and providers. Understanding your insurance policy and potential financial responsibilities, including separate bills from physicians and ancillary services, is also crucial.
What awards or recognition has University of Virginia Health System received?
The University of Virginia Health System in Charlottesville, Virginia, stands out for its exceptional research and care, earning the title of Best Hospital in Virginia in Newsweek's "World’s Best Hospitals 2022" and a Top Teaching Hospital by the Leapfrog Group. It has also received the highest rating for care in 5 specialties and 14 common conditions and procedures according to U.S. News & World Report. Furthermore, the University of Virginia School of Medicine has recognized its researchers with prestigious awards like the Distinguished Research Award and the Research Mentor Award for their groundbreaking contributions to medicine.